STOCK TITAN

CGNX (NASDAQ: CGNX) insider sales report $13.74M proceeds from 232,926 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CGNX submitted Form 144 notices reporting proposed sales of Common Stock and disclosed recent dispositions by Robert J. Willett. The filing lists proposed sales tied to option-related transactions dated 05/07/2026 and three reported dispositions in the prior three months.

Reported past sales: $10,300,974.15 for 177,052 shares on 02/12/2026, $127,808.48 for 2,148 shares on 02/13/2026, and $3,312,316.58 for 53,726 shares on 05/06/2026. The filing also lists proposed sale quantities of 101,256, 120,946, 121,672, 59,630, and 19,974 shares dated 05/07/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 filings document planned dispositions and recent insider sales by a reporting person.

The filing lists multiple proposed sales dated 05/07/2026 tied to option-derived Common Stock quantities and shows three actual dispositions by Robert J. Willett totaling 232,926 shares and $13,740,098.21 across February and May 2026.

These filings are routine notifications of transfers under Rule 144. Cash-flow recipients and whether transactions were brokered or part of planned arrangements are not specified in the excerpt; subsequent SEC filings may provide additional context.

Disposition - 02/12/2026 177,052 shares sale proceeds <money>$10,300,974.15</money>
Disposition - 02/13/2026 2,148 shares sale proceeds <money>$127,808.48</money>
Disposition - 05/06/2026 53,726 shares sale proceeds <money>$3,312,316.58</money>
Total recent dispositions 232,926 shares aggregate of three reported sales
Total reported proceeds <money>$13,740,098.21</money> aggregate proceeds from the three sales
Proposed sale line items 101,256; 120,946; 121,672; 59,630; 19,974 shares quantities listed with date <date>05/07/2026</date>
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Option Granted financial
"Option Granted - 02/21/2023"
Issuer legal
"Issuer | | | 101256 | 05/07/2026"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CGNX Form 144 report?

It reports proposed sales of Common Stock and recent insider dispositions. The filing lists proposed sale quantities dated 05/07/2026 and three dispositions by Robert J. Willett in Feb–May 2026.

How many shares did Robert J. Willett sell recently (CGNX)?

He reported three dispositions totaling 232,926 shares. Sales: 177,052 on 02/12/2026, 2,148 on 02/13/2026, and 53,726 on 05/06/2026.

What proceeds were reported for the recent CGNX sales?

Reported gross proceeds total $13,740,098.21. Proceeds: $10,300,974.15, $127,808.48, and $3,312,316.58 on the respective sale dates.

Are the proposed sale quantities in the CGNX Form 144 tied to option exercises?

Yes. The filing lists proposed Common Stock sales dated 05/07/2026 described alongside earlier option grant dates (2018–2024), with specific share quantities shown for each line item.

Does the Form 144 specify who receives the sale proceeds for CGNX?

The excerpt does not state proceeds recipients. The securities lines show 'Issuer' and 'Cash' labels but do not explicitly describe who will receive sale proceeds in the provided excerpt.